Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × INDUSTRY × Gout × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 54 Breast Neoplasms 54 Prostatic Neoplasms 35 Carcinoma, Non-Small-Cell Lung 34 Neoplasm Metastasis 20 Colorectal Neoplasms 18 Pain 17 Multiple Myeloma 15 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Anemia 14 Keratosis, Actinic 12 Lung Neoplasms 11 Carcinoma, Renal Cell 10 Cancer Pain 10 Lymphoma, Non-Hodgkin 9 Lymphoma, Follicular 9 Leukemia 9 Carcinoma, Hepatocellular 9 Carcinoma 9 Melanoma 8 Leukemia, Lymphocytic, Chronic, B-Cell 7 Uterine Cervical Neoplasms 6 Recurrence 6 Ovarian Neoplasms 6 Neuroendocrine Tumors 6 Lymphoma 6 Stomatitis 5 Lymphoma, T-Cell, Cutaneous 5 Leukemia, Myeloid, Acute 5 Glioblastoma 5

Interventions

Omeprazole 1 Naproxen 1 Febuxostat 1 Colchicine 1 Allopurinol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed

196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡